bpc 157 safety human study adverse effects BPC-157: Tendon Repair and More BPC-157 for athletes and injury
Description
Understanding the pharmacology shapes the dosage logic
Minimum monitoring capability should include: Baseline labs fasting glucose or A1c lipid panel CMP CBC When manipulating GH axis: IGF-1 Clinical monitoring body composition blood pressure heart rate symptom tracking If outcomes cannot be monitored, the stack should not proceed
Mild headache (uncommon)
This may indicate the predictive value of mutant p53 for responses to ICB in lung cancer
